Proposing a Generic Labeling Change Could Land FDA With More Work
This article was originally published in RPM Report
Executive Summary
Opponents of FDA’s November proposed rule on generic labeling don’t necessarily think the the best option is to maintain the status quo – but the other option is to give FDA more responsibility.